Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 996

1.

Drug susceptibility testing and mortality in patients treated for tuberculosis in high-burden countries: a multicentre cohort study.

Zürcher K, Ballif M, Fenner L, Borrell S, Keller PM, Gnokoro J, Marcy O, Yotebieng M, Diero L, Carter EJ, Rockwood N, Wilkinson RJ, Cox H, Ezati N, Abimiku AG, Collantes J, Avihingsanon A, Kawkitinarong K, Reinhard M, Hömke R, Huebner R, Gagneux S, Böttger EC, Egger M; International epidemiology Databases to Evaluate AIDS (IeDEA) consortium.

Lancet Infect Dis. 2019 Feb 7. pii: S1473-3099(18)30673-X. doi: 10.1016/S1473-3099(18)30673-X. [Epub ahead of print]

PMID:
30744962
2.

Whole genome sequencing for drug resistance profile prediction in Mycobacterium tuberculosis.

Gygli SM, Keller PM, Ballif M, Blöchliger N, Hömke R, Reinhard M, Loiseau C, Ritter C, Sander P, Borrell S, Loo JC, Avihingsanon A, Gnokoro J, Yotebieng M, Egger M, Gagneux S, Böttger EC.

Antimicrob Agents Chemother. 2019 Feb 4. pii: AAC.02175-18. doi: 10.1128/AAC.02175-18. [Epub ahead of print]

3.

Trends in influenza vaccination uptake in Switzerland: Swiss Health Survey 2007 and 2012.

Zürcher K, Zwahlen M, Berlin C, Egger M, Fenner L.

Swiss Med Wkly. 2019 Jan 23;149:w14705. doi: smw.2019.14705. eCollection 2019 Jan 14.

4.

Should Sentinel Lymph Node Biopsy Be Performed for All T1b Melanomas in the New 8th Edition American Joint Committee on Cancer Staging System?

Egger ME, Stevenson M, Bhutiani N, Jordan AC, Scoggins CR, Philips P, Martin RC 2nd, McMasters KM.

J Am Coll Surg. 2019 Jan 17. pii: S1072-7515(19)30041-9. doi: 10.1016/j.jamcollsurg.2018.12.030. [Epub ahead of print]

PMID:
30660817
5.

Automatic Detection and Classification of Ca2+ Release Events in Line- and Frame-Scan Images.

Illaste A, Wullschleger M, Fernandez-Tenorio M, Niggli E, Egger M.

Biophys J. 2019 Feb 5;116(3):383-394. doi: 10.1016/j.bpj.2018.12.013. Epub 2018 Dec 25.

PMID:
30638961
6.

Prevalence of sleep-disordered breathing after stroke and TIA: A meta-analysis.

Seiler A, Camilo M, Korostovtseva L, Haynes AG, Brill AK, Horvath T, Egger M, Bassetti CL.

Neurology. 2019 Feb 12;92(7):e648-e654. doi: 10.1212/WNL.0000000000006904. Epub 2019 Jan 11.

PMID:
30635478
7.

Global temporal changes in the proportion of children with advanced disease at the start of combination antiretroviral therapy in an era of changing criteria for treatment initiation.

Panayidou K, Davies MA, Anderegg N, Egger M; IeDEA, COHERE, PHACS and IMPAACT 219C Collaborations Writing Group.

J Int AIDS Soc. 2018 Nov;21(11):e25200. doi: 10.1002/jia2.25200.

8.

High prevalence of binge drinking among people living with HIV in four African countries.

Nouaman MN, Vinikoor M, Seydi M, Ekouevi DK, Coffie PA, Mulenga L, Tanon A, Egger M, Dabis F, Jaquet A, Wandeler G; IeDEA.

J Int AIDS Soc. 2018 Dec;21(12):e25202. doi: 10.1002/jia2.25202.

9.

The use of mathematical modeling studies for evidence synthesis and guideline development: A glossary.

Porgo TV, Norris SL, Salanti G, Johnson LF, Simpson JA, Low N, Egger M, Althaus CL.

Res Synth Methods. 2018 Dec 3. doi: 10.1002/jrsm.1333. [Epub ahead of print]

PMID:
30508309
10.

HIV drug resistance in sub-Saharan Africa: public health questions and the potential role of real-world data and mathematical modelling.

de Waal R, Lessells R, Hauser A, Kouyos R, Davies MA, Egger M, Wandeler G.

J Virus Erad. 2018 Nov 15;4(Suppl 2):55-58.

11.

IeDEA-WHO Research-Policy Collaboration: contributing real-world evidence to HIV progress reporting and guideline development.

Zaniewski E, Tymejczyk O, Kariminia A, Desmonde S, Leroy V, Ford N, Sohn AH, Nash D, Yotebieng M, Cornell M, Althoff KN, Rebeiro PF, Egger M.

J Virus Erad. 2018 Nov 15;4(Suppl 2):9-15.

12.

The contribution of observational studies in supporting the WHO 'treat all' recommendation for HIV/AIDS.

Ford N, Penazzato M, Vitoria M, Doherty M, Davies MA, Zaniewski E, Tymejczyk O, Egger M, Nash D.

J Virus Erad. 2018 Nov 15;4(Suppl 2):5-8.

13.

Inactivation of sphingosine-1-phosphate receptor 2 (S1PR2) decreases demyelination and enhances remyelination in animal models of multiple sclerosis.

Seyedsadr MS, Weinmann O, Amorim A, Ineichen BV, Egger M, Mirnajafi-Zadeh J, Becher B, Javan M, Schwab ME.

Neurobiol Dis. 2019 Apr;124:189-201. doi: 10.1016/j.nbd.2018.11.018. Epub 2018 Nov 22.

PMID:
30468865
14.

Challenges in assessing the sunscreen-melanoma association.

Rueegg CS, Stenehjem JS, Egger M, Ghiasvand R, Cho E, Lund E, Weiderpass E, Green AC, Veierød MB.

Int J Cancer. 2018 Nov 16. doi: 10.1002/ijc.31997. [Epub ahead of print]

PMID:
30447006
15.

Estimating the contribution of studies in network meta-analysis: paths, flows and streams.

Papakonstantinou T, Nikolakopoulou A, Rücker G, Chaimani A, Schwarzer G, Egger M, Salanti G.

Version 2. F1000Res. 2018 May 18 [revised 2018 Jan 1];7:610. doi: 10.12688/f1000research.14770.2. eCollection 2018.

16.

ASO Author Reflections: The Sentinel Lymph Node in Melanoma: Now More Important Than Ever.

Egger ME, McMasters KM.

Ann Surg Oncol. 2018 Dec;25(Suppl 3):906-907. doi: 10.1245/s10434-018-6855-1. Epub 2018 Oct 11. No abstract available.

PMID:
30311165
17.

Virologic failure and HIV drug resistance on simplified, dolutegravir-based maintenance therapy: Systematic review and meta-analysis.

Wandeler G, Buzzi M, Anderegg N, Sculier D, Béguelin C, Egger M, Calmy A.

F1000Res. 2018 Aug 30;7:1359. doi: 10.12688/f1000research.15995.1. eCollection 2018.

18.

A model for predicting low probability of nonsentinel lymph node positivity in melanoma patients with a single positive sentinel lymph node.

Bhutiani N, Egger ME, Stromberg AJ, Gershenwald JE, Ross MI, Philips P, Martin RCG 2nd, Scoggins CR, McMasters KM.

J Surg Oncol. 2018 Nov;118(6):922-927. doi: 10.1002/jso.25193. Epub 2018 Sep 27.

PMID:
30259521
19.

Ductal carcinoma in situ current trends, controversies, and review of literature.

Hong YK, McMasters KM, Egger ME, Ajkay N.

Am J Surg. 2018 Nov;216(5):998-1003. doi: 10.1016/j.amjsurg.2018.06.013. Epub 2018 Jun 18. Review.

PMID:
30244816
20.

Evaluation of sex-specific cut-off values of high-sensitivity cardiac troponin I and T assays in an emergency department setting - Results from the Linz Troponin (LITROP) study.

Mueller T, Egger M, Peer E, Jani E, Dieplinger B.

Clin Chim Acta. 2018 Dec;487:66-74. doi: 10.1016/j.cca.2018.09.026. Epub 2018 Sep 15.

PMID:
30227114
21.

Prediction of Real-World Drug Effectiveness Prelaunch: Case Study in Rheumatoid Arthritis.

Didden EM, Ruffieux Y, Hummel N, Efthimiou O, Reichenbach S, Gsteiger S, Finckh A, Fletcher C, Salanti G, Egger M; IMI GetReal Work Package 4.

Med Decis Making. 2018 Aug;38(6):719-729. doi: 10.1177/0272989X18775975.

PMID:
30074882
22.

What Should we do When HIV-Positive Children Fail First-Line Combination Antiretroviral Therapy? A Comparison of 4 ART Management Strategies.

Patten G, Schomaker M, Davies MA, Rabie H, van Zyl G, Technau K, Eley B, Boulle A, Van Dyke RB, Patel K, Sipambo N, Wood R, Tanser F, Giddy J, Cotton M, Nuttall J, Essack G, Karalius B, Seage G lll, Sawry S, Egger M, Fairlie L; for IeDEA Southern Africa.

Pediatr Infect Dis J. 2018 Jul 31. doi: 10.1097/INF.0000000000002156. [Epub ahead of print]

PMID:
30067598
23.

Safety and efficacy of irreversible electroporation in the treatment of obstructive jaundice in advanced hilar cholangiocarcinoma.

Martin EK, Bhutiani N, Egger ME, Philips P, Scoggins CR, McMasters KM, Kelly LR, Vitale GC, Martin RCG.

HPB (Oxford). 2018 Nov;20(11):1092-1097. doi: 10.1016/j.hpb.2018.06.1806. Epub 2018 Jul 26.

PMID:
30057125
24.

Atypical "hairy cell-like" presentation of leukemic mantle cell lymphoma.

Robier C, Hoefler G, Egger M, Hubmann E.

Clin Chem Lab Med. 2018 Dec 19;57(2):e34-e36. doi: 10.1515/cclm-2018-0633. No abstract available.

PMID:
30032129
25.

Obstruction of ventricular Ca2+ -dependent arrhythmogenicity by inositol 1,4,5-trisphosphate-triggered sarcoplasmic reticulum Ca2+ release.

Blanch I Salvador J, Egger M.

J Physiol. 2018 Sep;596(18):4323-4340. doi: 10.1113/JP276319. Epub 2018 Aug 7.

PMID:
30004117
26.

Planning a future randomized clinical trial based on a network of relevant past trials.

Salanti G, Nikolakopoulou A, Sutton AJ, Reichenbach S, Trelle S, Naci H, Egger M.

Trials. 2018 Jul 11;19(1):365. doi: 10.1186/s13063-018-2740-2.

27.

Heller Myotomy: To Wrap or Not to Wrap?

Brown J, Egger M, Kehdy FJ.

Am Surg. 2018 Jun 1;84(6):1022-1026.

PMID:
29981642
28.

5th generation cardiac troponin I and T assays in clinical routine - A head-to-head comparison with data from the Linz troponin (LITROP) study.

Mueller T, Egger M, Peer E, Dieplinger B.

Clin Chim Acta. 2018 Oct;485:195-204. doi: 10.1016/j.cca.2018.06.027. Epub 2018 Jun 27.

29.

Differential expression of ABCB5 in BRAF inhibitor-resistant melanoma cell lines.

Xiao J, Egger ME, McMasters KM, Hao H.

BMC Cancer. 2018 Jun 22;18(1):675. doi: 10.1186/s12885-018-4583-3.

30.

No Impact of Hepatitis B Virus Infection on Early Mortality Among Human Immunodeficiency Virus-Infected Patients in Southern Africa.

Hector J, Vinikoor M, Chilengi R, Ehmer J, Egger M, Wandeler G; IeDEA-Southern Africa.

Clin Infect Dis. 2018 Sep 28;67(8):1310-1311. doi: 10.1093/cid/ciy304. No abstract available.

PMID:
29912371
31.

Outcomes of Patients Lost to Follow-up in African Antiretroviral Therapy Programs: Individual Patient Data Meta-analysis.

Chammartin F, Zürcher K, Keiser O, Weigel R, Chu K, Kiragga AN, Ardura-Garcia C, Anderegg N, Laurent C, Cornell M, Tweya H, Haas AD, Rice BD, Geng EH, Fox MP, Hargreaves JR, Egger M.

Clin Infect Dis. 2018 Nov 13;67(11):1643-1652. doi: 10.1093/cid/ciy347.

32.

Treatment and outcome of AIDS-related Kaposi sarcoma in South Africa, Malawi and Zambia: an international comparison.

Rohner E, Kasaro M, Msadabwe-Chikuni SC, Stinson K, Mohamed Z, Tweya H, Egger M, Bohlius J.

Pan Afr Med J. 2017 Nov 24;28:261. doi: 10.11604/pamj.2017.28.261.11300. eCollection 2017.

33.

Impact of placebo arms on outcomes in antidepressant trials: systematic review and meta-regression analysis.

Salanti G, Chaimani A, Furukawa TA, Higgins JPT, Ogawa Y, Cipriani A, Egger M.

Int J Epidemiol. 2018 Oct 1;47(5):1454-1464. doi: 10.1093/ije/dyy076.

34.

Methods to systematically review and meta-analyse observational studies: a systematic scoping review of recommendations.

Mueller M, D'Addario M, Egger M, Cevallos M, Dekkers O, Mugglin C, Scott P.

BMC Med Res Methodol. 2018 May 21;18(1):44. doi: 10.1186/s12874-018-0495-9.

35.

Trends in the use of mammography for early breast cancer detection in Switzerland: Swiss Health Surveys 2007 and 2012.

Fenner L, Kässner A, Berlin C, Egger M, Zwahlen M.

Swiss Med Wkly. 2018 May 14;148:w14603. doi: 10.4414/smw.2018.14603. eCollection 2018.

36.

Differences in Pelvic Floor Symptoms During Pregnancy Between Hispanic and Non-Hispanic White Women.

Saltzman HM, Egger MJ, Bardsley T, Ding Q, Shaw JM, Nygaard IE.

Female Pelvic Med Reconstr Surg. 2018 Apr 28. doi: 10.1097/SPV.0000000000000592. [Epub ahead of print]

PMID:
29727374
37.

Antidepressants might work for people with major depression: where do we go from here?

Cipriani A, Salanti G, Furukawa TA, Egger M, Leucht S, Ruhe HG, Turner EH, Atkinson LZ, Chaimani A, Higgins JPT, Ogawa Y, Takeshima N, Hayasaka Y, Imai H, Shinohara K, Tajika A, Ioannidis JPA, Geddes JR.

Lancet Psychiatry. 2018 Jun;5(6):461-463. doi: 10.1016/S2215-0366(18)30133-0. Epub 2018 Apr 5. No abstract available.

PMID:
29628364
38.

Contagion and Public Health in Switzerland: Wilhelm Ost, MD (1853-1922), Polizeiarzt.

Fenner L, Zürcher K, Egger M.

Am J Public Health. 2018 May;108(5):629-630. doi: 10.2105/AJPH.2018.304344. No abstract available.

39.

Strengthening Routine Data Systems to Track the HIV Epidemic and Guide the Response in Sub-Saharan Africa.

Rice B, Boulle A, Baral S, Egger M, Mee P, Fearon E, Reniers G, Todd J, Schwarcz S, Weir S, Rutherford G, Hargreaves J.

JMIR Public Health Surveill. 2018 Apr 3;4(2):e36. doi: 10.2196/publichealth.9344.

40.

Occupational extremely low frequency magnetic fields (ELF-MF) exposure and hematolymphopoietic cancers - Swiss National Cohort analysis and updated meta-analysis.

Huss A, Spoerri A, Egger M, Kromhout H, Vermeulen R; Swiss National Cohort.

Environ Res. 2018 Jul;164:467-474. doi: 10.1016/j.envres.2018.03.022. Epub 2018 Mar 24.

PMID:
29587222
41.

Comparison between activated clotting time and anti-activated factor X activity for the monitoring of unfractionated heparin therapy in patients with aortic aneurysm undergoing an endovascular procedure.

Dieplinger B, Egger M, Luft C, Hinterreiter F, Pernerstorfer T, Haltmayer M, Mueller T.

J Vasc Surg. 2018 Aug;68(2):400-407. doi: 10.1016/j.jvs.2017.11.079. Epub 2018 Mar 20.

PMID:
29571622
42.

Commentary: Effect of Probiotic Supplementation on Cognitive Function and Metabolic Status in Alzheimer's Disease: A Randomized, Double-Blind and Controlled Trial.

Leblhuber F, Egger M, Schuetz B, Fuchs D.

Front Aging Neurosci. 2018 Mar 6;10:54. doi: 10.3389/fnagi.2018.00054. eCollection 2018. No abstract available.

43.

Developing WHO guidelines: Time to formally include evidence from mathematical modelling studies.

Egger M, Johnson L, Althaus C, Schöni A, Salanti G, Low N, Norris SL.

Version 2. F1000Res. 2017 Aug 29 [revised 2018 Jan 1];6:1584. doi: 10.12688/f1000research.12367.2. eCollection 2017.

44.

Death at no cost? Persons with no health insurance claims in the last year of life in Switzerland.

Panczak R, von Wyl V, Reich O, Luta X, Maessen M, Stuck AE, Berlin C, Schmidlin K, Goodman DC, Egger M, Clough-Gorr K, Zwahlen M.

BMC Health Serv Res. 2018 Mar 14;18(1):178. doi: 10.1186/s12913-018-2984-2.

45.

Technical comment on: Hagner M. Open access, data capitalism and academic publishing.

Egger M, Kalt A.

Swiss Med Wkly. 2018 Mar 14;148:w14611. doi: 10.4414/smw.2018.14611. eCollection 2018. No abstract available.

46.

CPAP as treatment of sleep apnea after stroke: A meta-analysis of randomized trials.

Brill AK, Horvath T, Seiler A, Camilo M, Haynes AG, Ott SR, Egger M, Bassetti CL.

Neurology. 2018 Apr 3;90(14):e1222-e1230. doi: 10.1212/WNL.0000000000005262. Epub 2018 Mar 9.

PMID:
29523641
47.

Issues with measuring hepatitis prevalence in resource-limited settings.

Wandeler G, Coffie PA, Kuniholm MH, Ocama P, Egger M.

Lancet. 2018 Mar 3;391(10123):835-836. doi: 10.1016/S0140-6736(18)30463-X. No abstract available.

PMID:
29508740
48.

Unique Genes in Tumor-Positive Sentinel Lymph Nodes Associated with Nonsentinel Lymph Node Metastases in Melanoma.

Egger ME, Xiao D, Hao H, Kimbrough CW, Pan J, Rai SN, Cambon AC, Waigel SJ, Zacharias W, McMasters KM.

Ann Surg Oncol. 2018 May;25(5):1296-1303. doi: 10.1245/s10434-018-6377-x. Epub 2018 Mar 1.

PMID:
29497912
49.

Living network meta-analysis compared with pairwise meta-analysis in comparative effectiveness research: empirical study.

Nikolakopoulou A, Mavridis D, Furukawa TA, Cipriani A, Tricco AC, Straus SE, Siontis GCM, Egger M, Salanti G.

BMJ. 2018 Feb 28;360:k585. doi: 10.1136/bmj.k585. Review.

50.

Retention and mortality on antiretroviral therapy in sub-Saharan Africa: collaborative analyses of HIV treatment programmes.

Haas AD, Zaniewski E, Anderegg N, Ford N, Fox MP, Vinikoor M, Dabis F, Nash D, Sinayobye JD, Niyongabo T, Tanon A, Poda A, Adedimeji AA, Edmonds A, Davies MA, Egger M; African regions of the International epidemiologic Databases to Evaluate AIDS (IeDEA).

J Int AIDS Soc. 2018 Feb;21(2). doi: 10.1002/jia2.25084.

Supplemental Content

Support Center